GluN2A(D731N) enhances sensitivity to endogenous proton and zinc ions. by Kai Gao (120150)

“…<p>(<b>A</b>) The composite proton concentration-response curves show an enhanced sensitivity of the GluN2A(D731N)-containing receptors to proton compared to the WT NMDA receptors; the abscissa shows hydrogen ion activity. …”

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity-10 by Rodrigo A Fuentealba (77901)

“…<p><b>Copyright information:</b></p><p>Taken from "ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity"</p><p>http://www.molecularneurodegeneration.com/content/2/1/14</p><p>Molecular Neurodegeneration 2007;2():14-14.…”

Decreased type 1 IFN and enhanced MHV-68 loads in lungs of TLR2- and MyD88-deficient mice. by François Michaud (360245)

GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

“…<p>(<b>A,B</b>) Representative TEVC recordings obtained from oocytes expressing WT GluN1/GluN2A (WT 2A) receptors (<b>A</b>) and GluN1/GluN2A(D731N) (2A-D731N) receptors (<b>B</b>) in which the currents were evoked by increasing concentrations (μM) of glutamate (in the presence of 100 μM glycine) at the holding potential of -40 mV. …”

Decreased clearance of IgAN patient IgA by CD89-expressing Kupffer cells. by Lijun Xu (195394)

“…(C) Decreased clearance of 10 μg IgAN patient-derived IgA in C57BL/6-Tg mice when compared to normal human IgA. …”

Decreased cell integrity and an increased number of intracellular membrane compartments in <i>ap1b1</i> mutant HCs. by Rachel Clemens Grisham (402043)

Loss of SRC-2 results in decreased expression of several cardiac transcription factors important for controlling metabolic and sarcomeric gene expression. by Erin L. Reineke (107382)

LS-PGC-1β^−/− mice exhibit decreased expression of TCA and ETC enzymes and mtDNA content. by Kari T. Chambers (106919)

S1/2^-/- mice display novelty induced hyperactivity, decreased anxiety and exploratory behavior and working memory disturbances. by Paul C. Baier (650225)

“…F-G) Y-maze test. WT: n = 23, S1/2^-/-: n = 20. F) S1/2^-/- mice showed increased activity in Y-maze test (E_genotype F_(1,41) = 10.98; p = 0.0019) most evident in interval 0-5 min (p_Bonf<0.01). …”

Impaired glucose metabolism and decreased insulin sensitivity in isolated adipocytes of Nscl-2−/−, Nscl-2−/−×ob/ob mice and controls. by Karen Ruschke (372824)

Enhanced Nrf2 activity decreases fatty acid transport and results in increased fatty acids content in white adipose tissue. by Jialin Xu (40952)

Figure S1 - VILIP-1 Expression <em>In Vivo</em> Results in Decreased Mouse Skin Keratinocyte Proliferation and Tumor Development by Jian Fu (41067)

LRP1 knockdown decreases the expression levels of GluA1 in neurons. by Ming Gan (673850)

Blocking VIP-signaling increased expression of costimulatory molecules and decreased expression of coinhibitory molecules on lymphocytes following mCMV infection. by Jian-Ming Li (319425)

c1 dKI mice have decreased CD4, T_fh, and IFNγ-producing T cells. by Kieran P. Manion (9179139)

Decreased phosphorylation of GSK3β-Ser9 in thrombin stimulated PP1cγ^−/− platelets. by Francisca C. Gushiken (368549)

“…Data are expressed as ±SEM of 5 experiments. (<b>D</b>) Effect of GSK3β inhibitor VIII on thrombin-induced fibrinogen binding on WT and PP1cγ^−/− platelets. …”

zQ175 mice displayed progressive motor deficits on balance beam and decreased locomotor activity in the Open Field chambers. by Qi Peng (702503)

Ultrasound imaging shows decreased density in treatment tumors. by Anthony B. Eason (6294305)

Dose-dependent decrease in Top1 levels in A375 xenografts. by Thomas D. Pfister (107712)

MCU is required for normal presynaptic Ca²⁺ clearance and MCU expression is decreased in LKB1-null hippocampi. by Seok-Kyu Kwon (3151941)